Literature DB >> 8897067

Differential expression of tenascin in the skin during hapten-induced dermatitis.

Y Koyama1, K Norose, M Kusubata, S Irie, M Kusakabe.   

Abstract

Tenascin is a large extracellular matrix glycoprotein which is found in limited regions of normal adult tissues including the skin. We investigated the induction of tenascin expression in mouse skin during hapten-induced dermatitis. In the dorsal skin, hapten application first induced a transient expression of tenascin in deeper regions of the skin. Its distribution then spread over the whole dermis corresponding to the infiltration of Mac-2-positive macrophages. In the ear, tenascin was consistently found in the subcutaneous tissue on the inner side, but very little was seen on the outer side. Tenascin did appear transiently, however, on both sides under hapten treatment. In the early phase of allergic contact dermatitis, no apparent induction of tenascin expression was observed in the swollen ear. However, there was an abundant tenascin expression on both sides during healing. Tenascin expressed under normal conditions was mostly the 180-kDa isoform, while the 230-kDa isoform was markedly induced during healing of the dermatitis. These results suggest that tenascin, particularly the larger 230-kDa isoform, may play important roles in the pathogenesis and healing of hapten-induced dermatitis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8897067     DOI: 10.1007/bf02473236

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  30 in total

1.  Tenascin, an extracellular matrix protein, exerts immunomodulatory activities.

Authors:  C R Rüegg; R Chiquet-Ehrismann; S S Alkan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  The distribution of immuno-reactive tenascin in the epithelial-mesenchymal junctional areas of benign and malignant squamous epithelia.

Authors:  R Anbazhagan; T Sakakura; B A Gusterson
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1990

3.  Nerve growth factor mediates monosialoganglioside-induced release of fibronectin and J1/tenascin from C6 glioma cells.

Authors:  E Yavin; A Gabai; S Gil
Journal:  J Neurochem       Date:  1991-01       Impact factor: 5.372

4.  Tenascin expression in hyperproliferative skin diseases.

Authors:  J Schalkwijk; I Van Vlijmen; B Oosterling; C Perret; R Koopman; J Van den Born; E J Mackie
Journal:  Br J Dermatol       Date:  1991-01       Impact factor: 9.302

5.  Increased expression of tenascin in the dermis in scleroderma.

Authors:  J P Lacour; A Vitetta; R Chiquet-Ehrismann; A Pisani; J P Ortonne
Journal:  Br J Dermatol       Date:  1992-10       Impact factor: 9.302

Review 6.  Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions.

Authors:  H P Erickson
Journal:  Curr Opin Cell Biol       Date:  1993-10       Impact factor: 8.382

7.  Inhibition of T cell activation by the extracellular matrix protein tenascin.

Authors:  T J Hemesath; L S Marton; K Stefansson
Journal:  J Immunol       Date:  1994-06-01       Impact factor: 5.422

8.  Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways.

Authors:  W J Rettig; H P Erickson; A P Albino; P Garin-Chesa
Journal:  J Cell Sci       Date:  1994-02       Impact factor: 5.285

9.  The extracellular matrix of lip wounds in fetal, neonatal and adult mice.

Authors:  D J Whitby; M W Ferguson
Journal:  Development       Date:  1991-06       Impact factor: 6.868

10.  Induction of tenascin in healing wounds.

Authors:  E J Mackie; W Halfter; D Liverani
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

View more
  5 in total

1.  Core-Shell Nanofibrous Scaffolds for Repair of Meniscus Tears.

Authors:  Jihye Baek; Martin K Lotz; Darryl D D'Lima
Journal:  Tissue Eng Part A       Date:  2019-08-14       Impact factor: 3.845

2.  Elongated dermatan sulphate in post-inflammatory healing skin distributes among collagen fibrils separated by enlarged interfibrillar gaps.

Authors:  K Kuwaba; M Kobayashi; Y Nomura; S Irie; Y Koyama
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

3.  Meniscal Tissue Engineering Using Aligned Collagen Fibrous Scaffolds: Comparison of Different Human Cell Sources.

Authors:  Jihye Baek; Sujata Sovani; Wonchul Choi; Sungho Jin; Shawn P Grogan; Darryl D D'Lima
Journal:  Tissue Eng Part A       Date:  2017-06-13       Impact factor: 3.845

4.  Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype.

Authors:  Claire Deligne; Devadarssen Murdamoothoo; Anís N Gammage; Martha Gschwandtner; William Erne; Thomas Loustau; Anna M Marzeda; Raphael Carapito; Nicodème Paul; Inés Velazquez-Quesada; Imogen Mazzier; Zhen Sun; Gertraud Orend; Kim S Midwood
Journal:  Cancer Immunol Res       Date:  2020-01-15       Impact factor: 11.151

5.  Proof of Concept Study for Increasing Tenascin-C-Targeted Drug Delivery to Tumors Previously Subjected to Therapy: X-Irradiation Increases Tumor Uptake.

Authors:  Aya Sugyo; Atsushi B Tsuji; Hitomi Sudo; Kanako Takano; Moriaki Kusakabe; Tatsuya Higashi
Journal:  Cancers (Basel)       Date:  2020-12-05       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.